Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Emcure Pharmaceuticals Ltd

EMCURE:NSI

Emcure Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,440.80
  • Today's Change-4.65 / -0.32%
  • Shares traded7.90k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 01 2024 13:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Emcure Pharmaceuticals Ltd is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical products across several therapeutic areas. It offers a range of products and services under formulations, biologics, and Active Pharmaceutical Ingredients (APIs). It focuses on various key therapeutic areas, such as gynecology, cardiology, anti-infective, diabetes, biologics, mRNA vaccines, and vitamin, minerals and nutrients. It offers products in both, chronic and acute segments. The Company's subsidiary, Gennova Biopharmaceuticals Limited, is a biotechnology company dedicated to developing, producing, and commercializing bio-therapeutics to address life-threatening diseases across various indications. It has developed two platforms: Mammalian and Microbial. Its key APIs consists of S-Amlodipine, Dydrogesterone, Ferric Carboxymaltose, Ferrous Ascorbate, and Eribulin. It operates approximately 13 manufacturing facilities.

  • Revenue in INR (TTM)--
  • Net income in INR--
  • Incorporated1981
  • Employees11.15k
  • Location
    Emcure Pharmaceuticals LtdPlot P-IIIT-BT Park, M.I.D.C., HinjawadiPUNE 411057IndiaIND
  • Phone+91 2 035070033
  • Fax+91 2 039821444
  • Websitehttps://www.emcure.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Eris Lifesciences Ltd24.98bn3.48bn180.09bn3.08k51.746.4928.917.2125.5725.57183.35203.740.45852.905.968,110,753.006.7313.428.3916.8077.0379.9814.6924.960.85993.410.4626--19.2315.392.576.1527.72--
Wockhardt Ltd28.93bn-3.43bn185.39bn2.39k------6.41-23.75-23.75199.60--------12,084,380.00---4.56---8.2958.6655.26-12.17-12.70--0.0764----5.55-4.7317.17---4.71--
Neuland Laboratories Ltd.16.35bn3.36bn187.40bn1.65k55.76--47.0311.46261.94261.941,274.50--------9,922,259.00--9.25--12.7153.3247.8120.5511.99--29.52--7.1330.8418.5183.5178.7617.8863.45
Astrazeneca Pharma India Ltd13.88bn958.59m190.62bn940.00198.86--171.8713.7438.3438.34555.18--------14,761,520.00--11.78--19.6248.5154.646.9110.27--121.25--25.6229.1712.2162.6624.29-10.46--
Concord Biotech Ltd10.38bn3.13bn191.48bn1.38k61.15--52.1818.4529.9329.9399.19--------7,537,496.00--------77.16--30.18----115.93----19.20--28.33------
Jubilant Pharmova Ltd69.20bn5.93bn191.94bn995.0032.413.2319.862.7737.3837.38436.41375.040.59341.758.1569,544,720.005.052.966.013.5568.5068.478.515.131.202.510.34224.736.70-5.95226.43-33.086.482.13
Alembic Pharmaceuticals Ltd63.04bn6.30bn221.89bn14.86k35.23--24.513.5232.0432.04320.63--------4,242,974.00--10.72--14.2573.1065.989.9912.47--12.52--28.2910.199.6280.071.05-15.5914.87
Pfizer Ltd22.38bn6.18bn233.22bn1.72k37.756.2234.3610.42135.06135.06489.19819.900.52881.8311.1613,004,360.0014.6014.2217.0517.7165.0061.3727.6124.054.3046.210.026782.67-9.551.05-11.645.1433.359.24
Natco Pharma Ltd.42.21bn16.37bn251.28bn4.02k15.35--13.785.9591.3791.37235.68--------10,510,210.00--12.33--14.2583.4073.0538.7725.16--91.13--18.9647.7213.8194.0916.59-4.7114.87
Laurus Labs Ltd50.53bn1.31bn264.86bn6.01k201.926.4048.585.242.432.4393.7076.700.6021.183.068,412,186.001.5510.132.5216.4753.4447.632.5812.830.58181.810.402313.00-16.5517.07-79.6811.3621.6821.67
Gland Pharma Ltd58.58bn7.22bn272.02bn4.22k37.67--24.884.6443.8343.83355.57--------13,890,770.00--13.23--14.5661.0055.5812.3322.92--34.66--7.2656.2922.61-1.1011.3224.02--
Emcure Pharmaceuticals Ltd-100.00bn-100.00bn272.13bn11.15k--------------------------7.14--13.93--59.29--7.81------0.0011.237.14-6.3621.35-5.93--
J B Chemicals and Pharmaceuticals Ltd35.92bn5.87bn304.58bn5.31k53.02--41.458.4836.9936.99226.16--------6,764,044.00--15.77--18.8966.2761.1816.3416.06--21.04--33.0810.6316.2234.8423.3640.1537.42
Suven Pharmaceuticals Ltd9.34bn2.40bn334.35bn1.05k138.89--112.9935.789.469.4636.75--------8,883,019.00--23.17--26.2056.5958.8525.7333.21--33.74--18.63-21.5622.71-26.9922.41-1.83--
Piramal Pharma Ltd87.04bn453.30m354.33bn6.72k787.954.4844.044.070.34070.340766.3659.910.57991.404.8812,954,040.000.302--0.428--63.69--0.5208--0.56037.490.3771--15.39--109.56------
Ajanta Pharma Ltd44.91bn8.75bn382.82bn7.84k44.0610.4137.838.5269.5569.55356.94294.360.97381.334.165,725,128.0018.9716.6123.2920.4775.7773.2219.4819.312.1349.880.008831.2012.4515.4138.8116.10-14.9710.76
Data as of Nov 01 2024. Currency figures normalised to Emcure Pharmaceuticals Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

2.81%Per cent of shares held by top holders
HolderShares% Held
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 30 Sep 20241.50m0.79%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 30 Sep 2024959.41k0.51%
Mahindra Manulife Investment Management Pvt Ltd.as of 30 Sep 2024695.00k0.37%
Bajaj Finserv Asset Management Ltd.as of 30 Sep 2024446.93k0.24%
ICICI Prudential Life Insurance Co. Ltd. (Invt Port)as of 30 Sep 2024343.65k0.18%
ICICI Prudential Asset Management Co. Ltd.as of 30 Sep 2024297.61k0.16%
Goldman Sachs Asset Management LPas of 30 Aug 2024291.00k0.15%
Axis Asset Management Co. Ltd.as of 30 Sep 2024285.55k0.15%
Bandhan AMC Ltd.as of 30 Sep 2024282.26k0.15%
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 30 Sep 2024223.11k0.12%
More ▼
Data from 30 Jun 2024 - 24 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.